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Prostaglandins of the E-series (PGEs) and PGI 2 will inhibit formylmethionylleucylphenylalanine- (f-Met- 
Leu-Phe) induced lysosomal enzyme release and superoxide-anion (Oz-) production by neutrophils. The 
inhibitory effects of PGEs and PGI 2 on neutrophii functional responses have been correlated with their 
ability to increase intracellular cAMP. In this study we have examined the effects of PGEs and PGI 2 on 
f-Met-Leu-Phe- and phorbol-myristate-acetate-induced rat neutrophil membrane potential changes using an 
optical probe of membrane potential 3,3-dipropylthiodicarbocyanine iodide. 15-(S)-15-methyI-PGE 1 (15- 
methyI-PGEi), a stable analogue of PGE t and PGI 2 inhibited f-Met-Leu-Phe-induced transmembrane 
potential changes in a dose-dependent manner. This inhibition was correlated with the ability of these agents 
to increase intracellular cAMP levels and inhibit 02-" production and degranulation. In contrast, 15-methyl- 
PGE t and PGI z, did not inhibit phorbol-myristate-acetate-induced transmembrane potential changes and 
O 2- production. These results suggest independent mechanisms of activation of neutrophils by phorbol 
myristate acetate and f-Met-Leu-Phe, and they also suggest that the inhibitory effects of prostaglandins and 
cAMP on f-Met-Leu-Phe-stimulated cells is at a step or steps prior to activation of those processes involved 
in effecting changes in transmembrane potential, which are common to both stimuli. 
Introduction 
Stimulation of certain neutrophil functions by 
f-Met-Leu-Phe is initiated by its binding to a 
specific formyl peptide receptor on the plasma 
membrane. One of the early events following the 
binding of f-Met-Leu-Phe to its receptor is a change 
in sodium, potassium and calcium ion fluxes across 
the plasma membrane, associated with a change in 
the transmembrane potential. These events have 
been shown to precede the release of superoxide 
Abbreviations: f-Met-Leu-Phe, N-formylmethionyileucyl- 
phenylalanine; AF, relative fluorescence change; TPCK, tosyl- 
L-phenylalanylchloromethyl ketone; di(S)-C3-(5 ), 3,3'-dipro- 
pylthiodicarbocyanine iodide; PGE1, prostaglandin El; 15- 
methyl-PGE1, 15-(S)-15-methyl-prostaglandin El; PGI 2, pros- 
taglandin I2; PGF2a, prostaglandin F2~. 
anion and lysosomal degranulation. A high degree 
of correlation of stimulus-induced changes in 
transmembrane potential with the production of 
O 2 and degranulation has been demonstrated 
[1-3]. 
Prostaglandins of the E series (PGEs) and PGI 2 
have been shown to inhibit  neutrophil-dependant 
inflammatory reactions m-vivo. Systemic treat- 
ment of rats with PGE 1 will inhibit immune com- 
plex-induced vasculitis in the skin [4], carra- 
geenin-induced inflammation in the rat footpad [5] 
and adjuvant arthritis [6]. In addition, pretreat- 
ment of neutrophils with PGEs or PGI 2 has been 
shown to inhibit neutrophil chemotaxis [7], aggre- 
gation [8] 0 2  production [9-11] and degranula- 
tion [12]. 
The inhibition of neutrophil stimulation by f- 
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Met-Leu-Phe is thought to be mediated by 
increases in intracellular cAMP levels induced by 
PGEs and PGI 2. Studies performed using mast 
cells and basophil leukemia cells lines have corre- 
lated the inhibition effects of prostaglandins and 
cAMP on calcium release and degranulation with 
their ability to inhibit cell membrane-associated 
phospholipid transmethylation reactions [13]. Ad- 
ditional studies suggest that the inhibitory effects 
of PGE a, PGI 2 and cAMP on platelet aggregation 
are secondary to their ability to decrease intracell- 
ular free-calcium levels after stimulation [14,15]. 
In an effort to clarify the mechanisms by which 
PGEs and PGI 2 modify neutrophil stimulation, we 
have investigated the effects of these agents on the 
transmembrane potential change associated with 
f-Met-Leu-Phe stimulation of rat neutrophils. We 
have found that PGEs, PGI 2 and other agents 
which increase intracellular cAMP levels inhibit 
f-Met-Leu-Phe-induced transmembrane potential 
changes at concentrations which also inhibit su- 
peroxide-anion production and degranulation. The 
data indicate that these agents can alter an early 
biophysical response of rat neutrophil plasma 
membrane to f-Met-Leu-Phe stimulation, and fur- 
ther suggest that this effect may be mediated by 
increases in intracellular cAMP levels. 
Materials and Methods 
Animals and chemicals. Adult female Long 
Evans rats, weighing approx. 400 g, were used 
throughout  this study. All chemicals were 
purchased from Sigma (St. Louis, MO), unless 
otherwise noted. Prostaglandins, including 15-(S)- 
15-methyl-PGE 1, were kindly provided by Dr. John 
Pike of the Upjohn Co. (Kalamazoo, MI). The 
cyanine dye 3,Y-dipropylthiodicarbocyanine 
(di(S)-C3-(5)) was obtained from Molecular Probes 
Incorporated (Junction City, OR). Prostaglandins 
were prepared as stock solutions in ethanol (10 
mg/ml). Cytochalasin B (5 mg/ml), and N-for- 
mylmethionylleucylphenylalanine were prepared 
and stored as 1 • 10 -2 M tock solutions in dimeth- 
ylsulfoxide at - 20 o C. 
Preparation of neutrophils and enzyme and Oj- 
assays. Cells were suspended in a balanced salt 
solution consisting of 138 mM NaC1/5.4 mM 
KC1/1.6 mM CAC12/0.8 mM MgSO4/0.8 mM 
Na2HPO4/0.8 mM I(H2PO4/10 mM Hepes (pH 
7.4). Neutrophils were obtained from rat peri- 
toneal cavities approx. 16 h after injection of 50 ml 
of 1.0% oyster glycogen in 0.9% of saline, as 
previously described [16]. Lysosomal enzyme re- 
lease was performed by incubating 2.106 cells in 
the presence of 5 pg/ml  cytochalasin B at varying 
concentrations of f-Met-Leu-Phe in a total volume 
of 250 #l for 10 min at 37°C. Reactions were 
terminated by placing the tubes in an ice-bath 
followed by centrifugation. N-Acetyl-fl-o-glucos- 
aminidase, lysozyme and lactate dehydrogenase 
activities were assayed in the supernatant, as previ- 
ously described [17,18]. All assays were performed 
in triplicate, and the data are expressed as per- 
centage of maximum (as assessed by using 0.1% 
Triton X-100 to lyse cells completely) enzyme re- 
lease (_S.E.). The amount of superoxide anion 
produced was determined by the superoxide dis- 
mutase-inhibitable reduction of ferricytochrome c 
by stimulated cells, as previously described [9], 
and the results are expressed as nmol O2/106 
cells per 10 min, using an extinction coefficient of 
21.2 cm -1 .mM -1 at 550 nm. All assays were 
performed in triplicate and data are expressed as 
mean values _+ S.E. 
Measurement of membrane potential changes. 
Membrane potential changes were measured as 
previously described [3]. Briefly, neutrophils (2. 
106 cells/ml) were exposed to 2.10 .6 M diS-Ca-(5 ) 
at 37 °C with constant stirring of the cell suspen- 
sion, until (usually after less than 5 min) there was 
no change in the fluorescence intensity as mea- 
sured using a Varian SF330 spectrofluorimeter. 
The cells were then stimulated with various con- 
centrations of f-Met-Leu-Phe or phorbol myristate 
acetate, and the maximum change in fluorescence 
(excitation at 622 nm, emission as 655 nm and 
band widths of 10 nm) was determined. The rest- 
ing membrane potential was determined using the 
'null-point' method as described previously [3]. 
Membrane potential changes were expressed as the 
maximum change in fluorescence (AF). 
Measurement of cAMP levels. 1.0 ml of rat 
neutrophils (5.10 6 cells/ml) were incubated in the 
presence or absence of prostaglandins for 5 rain at 
37 o C. The reaction was stopped by the addition 
of trichloroacetic acid, to a final concentration of 
6%. The supernates obtained after centrifugation 
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(2000 X g for 50 min) were extracted three times 
with diethylether (1.0 ml vol.) to remove trichloro- 
acetic acid. The aqueous phase was then evaporated 
to dryness. The dried samples were then resus- 
pended in 0.05 M sodium acetate (pH 6.2), and 
cAMP levels were determined by radioimmunoas- 
say (New England Nuclear, Boston MA). 
Statistical analysis. Student's t-test (two-tailed 
analysis) was used to compare the mean values of 
the responses of treated cells with those for non- 
treated control cells. P values less than 0.05 were 
considered statistically significant. 
Results 
Effects of prostaglandins on f-Met-Leu-Phe-induced 
transmembrane potential changes 
The effect of 15-methyl-PGE], a stable ana- 
logue of PGE 1 [4], on f-Met-Leu-Phe-induced 
changes in A F of rat neutrophils incubated with 
di(S)-C3-(5 ) was examined. 15-methyl-PGE] in- 
hibited f-Met-Leu-Phe-induced transmembrane 
potential changes in a dose-dependent manner 
(Fig. 1). 1 . 10  -4 M 15-methyl-PGEl inhibited f- 
Met-Leu-Phe-induced AF by more than 60% over 
a broad range of concentrations of stimulus. 1. 
10 -5 M 15-methyl-PGE] was much less effective 
in inhibiting f-Met-Leu-Phe-induced A F at each 
20 
<! 10 . . . - f ' J  
i / /j/~p ./.O 
5 ~ ,  / i 
- log  f met - l eu-phe  [M] 
Fig. 1. Inhibition of f-Met-Leu-Phe-induced transmembrane 
potential changes. 2.10 6 neutrophils/ml were equilibrated with 
di(S)-C3-(5 ) (2 vM,  final concentration). Varying doses of 
f-Met-Leu-Phe were added to cells pretreated for 5 rain at 
3 7 ° C  with; ethanol (0.1%, final concentration), ( O -  O), 
15-methyl-PGE 1 (10 -5  M), (zx---zx), and 15-methyl-PGE 1 (1. 
10-4  M), (D- - - - -D) .  Results are duplicate determinations with 
variations smaller than 10%. 
concentration of stimulus. Increasing concentra- 
tions of f-Met-Leu-Phe failed to overcome totally 
the inhibitory effects of 15-methyl-PGE1, even at 
concentrations of stimulus as high as 1 • 1 0  - 6  M. 
The inhibition of the f-Met-Leu-Phe-induced 
TABLE I 
EFFECT OF P R O S T A G L A N D I N S  ON f-Met-Leu-Phe-INDUCED CHANGES IN F L U O R E S C E N C E  OF diS-C3-(5)-TREATED 
RAT NEUTROPHILS.  
Rat polymorphonuclear neutrophils were equilibrated with diS-C3-(5 ) prior to pre-treatment with each reagent (37 o C, 5 min.). Cells 
were stimulated with f-Met-Leu-Phe, and the maximum change in fluorescent intensity (AF) was determined. AF values represent 
means + S.E. Each experiment shown is a representative example from at least three separate experiments, n.s., not significant. 
Treatment A F % inhibition P value 
f-Met-Leu-Phe (1.10 -6  M) 
f-Met-Leu-Phe + 15-methyl-PGE 1 (1 .10 -  5 M) 
f-Met-Leu-Phe + PGI 2 (1 .10 -  5 M) 
f-Met-Leu-Phe + PGF2a 
(1.10- 5 M) 
f-Met-Leu-Phe (1 .10 -7  M) 
f-Met-Leu-Phe + 15-methyl- 
-PGE 1 (3.10 -5  M) 
f-Met-Leu-Phe + dibutyryl 
cAMP ( 1 . 1 0 -  3 M) 
f-Met-Leu-Phe + 
isoproterenol ( 5 . 1 0 -  6 M) + 
theophylline ( 5 . 10 -  4 M) 
19.8 + 1.6 - - 
11.2+0.2 43.3 < 0.01 
12.2 + 1.9 38.1 < 0.05 
23.5 -t- 5.0 - 17.2 n.s. 
26.0 + 1.2 - - 
14.8 + 1.7 43.1 < 0.001 
14.5 + 2.0 44.2 < 0.001 
15.7 + 0.9 39.6 < 0.001 
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Fig. 2. Effect of 15-methyl-PGEt on f-Met-Leu-Phe-induced 
di(S)-C3-(5 ) fluorescence. 2.106 neutrophils/ml were equi- 
librated with di(S)-C3-(5) (2 /~M, final concentration). Cells 
were pre-treated ($) with either ethanol (0.1% final concentra- 
tion) ( ) or 15-methyl-PGE1 (10 ~tM, final concentra- 
tion) ( . . . . . .  ) for 5 min at 37 o C prior to stimulation with 
f-Met-Leu-Phe (1.10 -7 M, final concentration). The second 
arrow indicates addition of f-Met-Leu-Phe (FMLP). 
transmembrane potential change by 15-methyl- 
PGE] demonstrated a molecular class specificity, 
since PGI 2, but not PGF2a, also inhibited f-Met- 
Leu-Phe-induced fluorescence changes (Table I). 
Although 15-methyl-PGE] pretreatment of rat 
neutrophils decreased the maximum f-Met-Leu- 
Phe-induced transmembrane potential change, it 
did not alter the lag time to achieve maximal 
fluorescence (Fig. 2).After a 5 min preincubation 
of rat neutrophils with 15-methyl-PGE] (1.10 -5 
M), the fluorescence change with f-Met-Leu-Phe 
occurred rapidly, reaching a maximum within 60 s, 
followed by a gradual decrease in fluorescence. 
Pre-treatment of rat neutrophils with 15- 
methyl-PGE~ did not significantly alter the base- 
line fluorescence of di(S)-C3-(5) or the resting 
membrane potential. The resting membrane poten- 
tial of rat neutrophils in the absence of pros- 
taglandins was calculated to be -60.2 mV, while 
in the presence of 15-methyl-PGEt, (1.10 -4 M) 
the resting membrane potential was -58.0 mV. 
Both of these values are consistent with previously 
published values [19,20] and were not significantly 
different. 
The inhibitory effect of 15-methyl-PGE t on 
f-Met-Leu-Phe-induced transmembrane potential 
changes was reversible. Neutrophils which had 
been washed (twice) with buffered salt solution 
(see Materials and Methods) at 4°C and in- 
cubated at 37 °C for 10 min after pre-incubation 
with 15-methyl-PGE] (1 • 10 -s M) showed no in- 
hibition of f-Met-Leu-Phe-induced transmembrane 
potential changes (data not shown) and 0 2  pro- 
duction [9]. In addition, pre-incubation periods of 
30 s with 15-methyl-PGE] produced reproducible 
and significant inhibition of f-Met-Leu-Phe-in- 
duced transmembrane potential changes and O~- 
production (data not shown). This correlates with 
the rapid increase in intracellular cAMP levels 
associated with PGE] and PGI/exposure of neu- 
trophils [7,12]. 
Effect of dibutyryl cAMP and isoproterenol on f- 
Met-Leu-Phe-induced transmembrane potential 
changes 
Since the inhibitory effects of PGEs and PGI 2 
on neutrophil functional responses are thought to 
be mediated by activation of adenylate cyclase and 
increased intracellular cAMP levels, the effects of 
other agents known to elevate cAMP levels on 
f-Met-Leu-Phe-induced fluorescence changes were 
determinedl Both dibutyryl cAMP and isopro- 
terenol in the presence of theophylline inhibited 
f-Met-Leu-Phe-induced fluorescence changes in a 
dose-dependent manner (Table I). Preincubation 
of rat neutrophils with dibutyryl cAMP at a con- 
centration of 1 .10 -3 M inhibited f-Met-Leu-Phe- 
induced changes in transmembrane potential by 
44.2%. At concentrations of dibutyryl cAMP less 
than 1 .10 -4 M no inhibition of transmembrane 
potential changes was observed (data not shown). 
Isoproterenol (5- 10 -6 M) in the presence of theo- 
phylline (5.10 -4 M) (concentrations previously 
shown to produce significant increases in neu- 
trophil intracellular cAMP levels [7,12]), produced 
a similar degree of inhibition (39.6%) of f-Met- 
Leu-Phe-induced transmembrane potential 
changes. However, in the absence of theophylline 
or at concentrations of isoproterenol less then 
1 .10 -6 M, minimal inhibition of transmembrane 
potential changes was observed. 
Correlation of inhibition effects of prostaglandins on 
transmembrane potential changes with functional re- 
sponses 
The dose-dependent inhibitory effect on f-Met- 
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TABLE II 
EFFECT OF PROSTAGLANDINS ON PHORBOL-MYRISTATE-ACETATE-INDUCED CHANGES IN FLUORESCENCE OF 
di(S)-Ca-(5)-TREATED RAT NEUTROPHILS 
Rat polymorphonuclear neutrophils were treated as described in Table I. Cells were stimulated with phorbol myristate acetate, and the 
maximum change in fluorescent intensity ( A F )  was determined. A F  values represent means+S.E.  Each experiment shown is a 
representative example from at least three separate experiments, n.s., not significant. 
Treatment A F 5[ inhibition P value 
Phorbol myristate acetate 
(100 ng/ml)  16.6+0.2 - - 
Phorbol myristate acetate + 
15-methyl-PGE 1 (1.2.10- 4 M) 16.0 + 0.6 3.6 n.s. 
Phorboi myristate acetate + 
15-methyl-PGE 1 (6 .10-  5 M) 15.7 + 1.4 5.4 n.s. 
f-Met-Leu-Phe (1.10-  5 M) 16.5 + 0.3 - - 
f-Met-Leu-Phe + 
15-methyl-PGE 1 (6-10- 5 M) 10.7 + 0.9 35.2 < 0.001 
Phorbol myristate acetate 
(100 ng/ml)  19.2 + 1.3 - - 
Phorboi myristate acetate + 
15-methyl-PGE 1 (1-10-5 M) 20.2 + 1.3 - 1.1 n.s. 
Phorbol myristate acetate 
(10 ng/ml)  17.2 + 0.6 - - 
Phorbol myristate acetate + 
15-methyl-PGE 1 (1-10-  5 M) 16.7 + 0.3 2.9 n.s. 
f-Met-Leu-Phe (1-10-6 M) 30.0 + 1.2 - - 
f-Met-Leu-Phe + 15-methyl- 
PGE 1 (1.10 -5 M) 20.3 + 1.2 32.6 < 0.01 
TABLE III 
EFFECT OF PRE-TREATMENT OF RAT NEUTROPHILS WITH 15-METHYL-PGE1, PGI2, PGF2~, DIBUTYRYL cAMP 
AND DIBUTYRYL cGMP ON O{ SECRETION AND LYSOSOMAL ENZYME RELEASE 
Rat polymorphonuclear neutrophils were pre-incubated with the prostaglandins or cyclic nucleotides for 5 min (37 o C) prior to 
stimulation with f-Met-Leu-Phe, the production of 0 2 and secretion of N-acetyi-fl-D-glucosaminidase we, re determined. O~- secretion 
and enzyme release are expressed as the mean+- S.E.n.s., not significant. 
Treatment 0 2 (nmol/2.106 cells) 5[ inhibition P value N-Acetyl-fl-O- 5[ inhibition P value 
glucosaminidase 
5[ maximum enzyme 
f-Met-Leu-Phe (1 • 10- 6 M) 5.9+0.2 - - 1,4.7+_0.5 - - 
f-Met-Leu-Phe + 
15-methyl-PGE~ (1 .10-  4 M) 2.6 -1- 0.2 55.9 < 0.01 8.3 + 0.3 43.5 < 0.02 
f-Met-Leu-Phe + 
15-methyl-PGE 1 (1.10 -5 M) 3.3-t-0.4 44.1 < 0.05 11.2+0.3 23.8 < 0.05 
f-Met-Leu-Phe + 
PGI 2 (1 .10-  4 M) 2.5 + 0.1 57.6 < 0.01 9.2 + 0.2 37.4 < 0.01 
f-Met-Leu-Phe + 
PGI2 (1.10 -5 M) 3.7+-0.1 37.2 < 0.02 12.3 +0.1 16.3 < 0.05 
f-Met-Leu-Phe + 
PGF2a (1.10 -5 M) 5.5+-0.2 6.8 n.s. 14.2+-0.2 3.4 n.s. 
f-Met-Leu-Phe + 
dibutyryl cAMP (1.10 -3 M) 3.2+-0.1 45.7 < 0.02 11.8+-0.4 19.7 < 0.05 
f-Met-Leu-Phe + 
dibutyrylcGMP (1-10 -3 M) 5.9+-0.2 0.0 n.s. 15.0+0.3 2.0 n.s. 
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TABLE IV 
EFFECT OF PRE-TREATMENT OF RAT NEUTROPHILS WITH 15-METHYL-PGE 1 ON PHORBOL-MYRISTATE- 
ACETATE-INDUCED 0 2  SECRETION. 
Rat neutrophils (2.106 cells) were pre-incubated in the presence or absence of 15-methyl-PGE 1 (1.10 -4 M) at (37 o C, 5 min) and 
then stimulated with either phorbol myristate acetate of f-Met-Leu-Phe and incubated for an additional 10 min at 37 o C. The number 
of nmol of 0 2  produced was determined (see Materials and Methods). Values represent means+ S.E. Each experiment shown is a 
representative example from at least three separated experiments. HBSS, Hanks' balanced salt solution; n.s., not significant. 
Treatment O 2- (nmol/2.10 6 % inhibition P value 
cells) 
H BSS 3.0 + 0.4 - 
Phorbol myristate acetate 
(100 ng/ml) 44.7 + 0.3 - - 
(10 ng/ml) 39.6 + 1.0 - 
(1 ng/ml) 4.3 + 0.3 - - 
Phorbol myristate acetate 
(100 ng/ml)+ 15-methyl-PGE 1 (1.10-4 M) 49.3 + 1.6 - 10.3 n.s. 
(10 ng/ml + 15-methyl-PGE 1 (1.10- 4 M) 41.9 + 0.9 - 5.8 n.s. 
(1 ng/ml + 15-methyI-PGE I (1.10- 4 M) 4.5 + 0.1 - 4.6 n.s. 
HBSS + 15-methyl-PGE I (1.10 -4 M) 2.7 + 1.4 10.0 n.s. 
f-Met-Leu-Phe (1.10- 6 M) 5.75:0.1 - - 
f-Met-Leu-Phe (1.10 -4 M) 3.1 5:0.2 45.6 P < 0.01 
Leu-Phe-induced fluorescence changes by 15- 
methyl-PGEl and PGI 2 correlated with their in- 
hibitory effects on f-Met-Leu-Phe-induced super- 
oxide anion production and lysosomal enzyme re- 
lease (Table III). Concentrations of 15-methyl- 
PGE l and PGI  2 greater than 1 . 1 0  -5 M and di- 
butyryl cAMP (1 .10  -3 M) consistently inhibited 
f-Met-Leu-Phe-induced transmembrane potential 
changes and O~- production by approx. 40%. 
However, these agents appeared to be less effective 
in inhibiting f-Met-Leu-Phe-induced lysosomal en- 
zyme release. Although 15-methyl-PGE 1 and PGI2 
at relatively high concentrations (1 .10  -4 M) in- 
hibited N-acetyl-/3-D-glucosaminidase release to 
relatively the same degree as O~- and transmem- 
brane potential changes, at 1 . 1 0  -5 M there was 
only an approx. 20% inhibition of enzyme release 
compared to a 40% inhibition of 0 2  production 
and transmembrane potential change. A similar 
differential effect of dibuturyl cAMP on the func- 
tional response of rat neutrophils was observed. 
Dibutyryl cAMP at 1 • 10 -3 M inhibited lysosomal 
enzyme release by 19.7%, compared to a 45.7% 
inhibition of 0 2  production. In contrast, neither 
PGF2~ nor dibutyryl cGMP altered either the 
functional responses of the calls to f-Met-Leu-Phe 
or the f-Met-Leu-Phe-induced membrane potential 
changes. These data suggest a close correlation 
between changes in t ransmembrane potential and 
02- production and a partial dissociation between 
these two indices of neutrophil stimulation and 
degranulation. 
Effects of prostaglandins on cAMp levels 
The ability of 15-methyl-PGE 1 to increase rat 
neutrophil intraceUular cAMP levels was verified 
and was dose-dependent. At a concentration of 
1 • 10 -5 M 15-methyl-PGE a there was a 94% ( P  < 
0.001) increase in intracellular cAMP levels (Table 
V). This is a similar dose range in which consistent 
inhibition of f-Met-Leu-Phe-induced changes of 
both  fluorescence and functional responses were 
observed. However, at concentrations of 15- 
methyl-PGE 1 of 1 . 1 0  -6 M or theophylline of 5.  
10 -4 M, there was no consistent inhibition of 
either the f-Met-Leu-Phe-induced changes in 
t ransmembrane potential or functional responses, 
despite a 20-30% increase in intracellular cAMP 
levels. These observations suggest that significant 
elevations of intracellular cAMP levels of approx. 
100% above baseline levels are necessary for sig- 
nificant inhibition of f-Met-Leu-Phe-induced re- 
sponses of glycogen elicited rat neutrophils. 
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TABLE V 
EFFECT OF PROSTAGLANDIN E 1 AND THEOPHYLLINE ON INTRACELLULAR cAMP LEVELS OF RAT NEU- 
TROPHILS 
0.5 ml of rat polymorphonuclear neutrophils (1.107 ceUs/ml) were pre-incubated at 37 o C for 5 min. in the presence or absence of 
15-methyl-PGE 1 or theophylline. The reactions were terminated by the addition of trichloroacetic acid (final concentration 6~), and 
the concentrations of cAMP were determined. All assays were performed in triplicate and Student's t-test was used to compare treated 
with nontreated cells. Each experiment shown is a representative example from at least three separate experiments. 
Treatment cAMP concentration % increase P value 
(pmol/5.106 cells) 
None 4.01 + 0.07 
15-Methyl-PGE 1 (1.0/~ M) 5.15 + 0.25 28.4 < 0.05 
15-Methyl-PGE~ (10/~M) 7.79 + 0.32 94.0 < 0.001 
15-Methyl-PGE 1 (100 # M) 7.47 + 0.97 86.2 < 0.05 
Theophylline (5-10 -4 M) 4.80 + 0.06 19.7 < 0.02 
Effects of 15-metyl-PGE t on phorbol-myristate- 
acetate-induced responses 
In contrast to the inhibitory effects of 15- 
methyl-PGE 1 on f-Met-Leu-Phe-induced neu- 
trophil responses, no inhibition of phorbol-myri- 
state-acetate-induced membrane potential changes 
(Table II) and 0 2  production (Table IV) were 
observed over a range of doses of stimulus. These 
studies indicate a stimulus-specific inhibitory ef- 
fect of 15-methyl-PGE~ on the stimulated neu- 
trophil fluorescence changes of di(S)-C3-(5)-treated 
rat neutrophils and 0 2  production. 
Discussion 
Prostaglandins of the E series and PGI 2 have 
been shown to inhibit the production of 0 2 ,  
chemotaxis and secretion of lysosomal enzymes by 
neutrophils in response to a variety of stimuli, 
including f-Met-Leu-Phe [7-12]. However, there is 
a paucity of data examining the effect of pros- 
taglandins on the early biochemical and biophysi- 
cal events associated with stimulus-response cou- 
pling in the neutrophil. The data presented here 
demonstrate an inhibitory effect of 15-methyl- 
PGE 1 and PGI 2 on f-Met-Leu-Phe-induced mem- 
brane potential changes of rat neutr0phils. This is 
correlated with the inhibitory effects of 15-methyl- 
PGE 1, PGI 2 and other agents known to increase 
intracellular cAMP levels on f-Met-Leu-Phe- 
stimulated 0 2  production and lysosomal enzyme 
secretion. Other authors have demonstrated inhibi- 
tory effects of PGEs, PGI 2 and cAMP agonists on 
neutrophil functional responses in a variety of 
species [7-12]. This study correlates the inhibi'tory 
effects of these agents with their ability to inhibit 
o n e o f  the early events associated with stimulus-re- 
sponse coupling in the neutrophil, i.e., changes in 
cell transmembrane potential. 
Recently, Seligman et al. [21] observed a similar 
inhibition by histamine of f-Met-Leu-Phe-induced 
changes in transmembrane potential in human 
neutrophils. This inhibitory effect by histamine 
was correlated with its ability to inhibit f-Met- 
Leu-Phe-induced functional responses of human 
neutrophils and was blocked by H 1 receptor 
antagonist. Histamine has been shown by other 
authors to activate neutrolahil-adenylate cyclase 
and increase intracellular cAMP levels [22]. There- 
fore, similar mechanisms of inhibition of trans- 
membrane potential may underlie the inhibitory 
effect of histamine, PGEs and PGI z. This possibil- 
ity is supported by the close correlation between 
intracellular "cAMP elevation and inhibition of 
membrane potential changes. 
In contrast to the inhibitory effects of 15- 
methyl-PGE 1 on f-Met-Leu-Phe-induced 0 2 pro- 
duction and changes in membrane potential, 15- 
methyl-PGE~ did not inhibit either phorbol myri- 
state acetate induced membrane potential changes 
or 0 2 production. These observations further 
clarify the metabolic events associated with stimu- 
lus-response coupling in the neutrophil. Several 
laboratories have described distinct specific recep- 
tors for binding of f-Met-Leu-Phe and phorbol 
myristate acetate to neutrophils [17,24-27]. After 
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binding of f-Met-Leu-Phe to the formyl peptide 
receptor on the neutrophil, a complex series of 
events occurs. One of the earliest events includes 
changes in Na +, K + and Ca 2+ fluxes across the 
cell membrane and changes in transmembrane 
potential [1-3,28,29]. These changes in transmem- 
brane potential can be monitored by changes in 
the fluorescence intensity of a variety of cyanine 
dyes, including di(S)-C3-(5 ). Subsequent to changes 
in ion fluxes and transmembrane potential is the 
expression of the functional responses of the neu- 
trophil, including 0 2 production. Since neither 
15-methyl-PGE 1 nor dibutyryl cAMP altered 
phorbol-myristate-acetate-induced neutrophil re- 
sponses, it would appear that the primary inhibi- 
tory effect of prostaglandins and cAMP on f-Met- 
Leu-Phe-stimulated cells is at a step or steps prior 
to activation of those processes involved in effect- 
ing changes in transmembrane potential, which are 
common to both f-Met-Leu-Phe and phorbol 
myristate acetate stimulation. 
Two mechanisms for the inhibition of in- 
flammatory cell activation by prostaglandins and 
cAMP have been proposed. Studies performed 
using mast cells and basophil leukemia cell lines 
suggest that prostaglandins and adenylate cyclase 
agonists increase cAMP levels and inhibit cell 
membrane-associated phospholipid transmethyla- 
tion reactions that occur subsequent to cell stimu- 
lation and prior to calcium release and degranula- 
tion [13]. If similar mechanisms occur in f-Met- 
Leu-Phe-stimulated neutrophils, our data would 
suggest that phorphol myristate acetate stimula- 
tion of neutrophils does not require phospholipid 
transmethylation reactions for changes in mem- 
brane potiential and functional responses to occur, 
and/or  the methyltransferase activities associated 
with phorbol myristate acetate activation of hu- 
man neutrophils are not regulated by prostaglan- 
dins and cAMP. 
The second proposed mechanism for the inhibi- 
tory activity of prostaglandins as mediated via 
cAMP is that these agents alter the availability of 
intracellular free calcium. Studies performed using 
platelets in which transmethylation reactions do 
not appear to be a requirement for biological 
activity [30] indicate that PGI 2 and increased in- 
traceUular cAMP levels decrease intraceUular 
free-calcium levels after stimulation [14,15]. The 
data suggest that increased cAMP levels activate a 
calcium-dependent ATPase with increased seques- 
tration of free calcium in the dense tubular system. 
Stimulation of rabbit and human neutrophils with 
f-Met-Leu-Phe causes a rapid increase in free in- 
tracellular calcium, as determined using the 
calcium-sensitive fluorescent probe quin-2 [31]. 
This increase in intracellular calcium correlates 
with the ability of f-Met-Leu-Phe to induce neu- 
trophil degranulation and O 2 production. In addi- 
tion, pretreatment of neutrophils with the in- 
traceUular calcium antagonist, 8-( N, N-diethyl- 
amino)octyl-3,4,5-trimethoxybenzoate also inhibits 
f-Met-Leu-Phe-induced 02- production [32]. Thus, 
there is an abundance of data supporting the 
importance of intracellular calcium for stimulus- 
response coupling in the neutrophil. However, the 
role of intracellular free calcium as a second mes- 
senger associated with phorbol myristate acetate 
stimulation of neutrophils is less clear. Although 
8-( N, N-diethylamino)octyl-3,4,5-trimethoxyben- 
zoate inhibits phorbol-myristate-acetate-induced 
neutrophil Of  production [33], experiments by 
Sha'afi et al. [31], using quin-2, failed to demon- 
strate a rise in the level of free intracellular calcium 
with phorbol myristate acetate stimulation. This 
latter observation may explain the differential af- 
fects of prostaglandins on f-Met-Leu-Phe and 
phorbol-myristate-acetate-induced Of  production. 
The data support the hypothesis that prostaglan- 
dins and cAMP modulate intracellular free calcium 
levels as their primary mechanism of inhibiting 
neutrophil biologic responses. 
Additional effects of prostaglandins on cell 
membranes have been described. Kury et al. [34] 
observed increased deformability of PGEl-treated 
red blood cells and correlated these changes with a 
decrease in orientational relaxation times of fatty 
acid spin-labeled erythrocytes. They concluded that 
the fatty acid side chains in cell membrane phos- 
pholipids are more liquid or fluid in the presence 
of PGE 1. Therefore, it is possible that the inhibi- 
tory activity of 15-methyl-PGE 1 and PGI 2 toward 
neutrophils are in part secondary to direct altera- 
tions of the neutrophil plasma membrane's physi- 
cochemical properties. Three recent studies have 
described alterations in ligand-receptor interac- 
tions in prostaglandin treated platelets [35], mac- 
rophages [36] and neutrophils [16]. Of particular 
interest is the observation that neutrophils isolated 
from rats treated with 15-methyl-PGE 1 show de- 
creased lysosomal enzyme release and 0 2 produc- 
tion in response to f-Met-Leu-Phe stimulation [16]. 
This is associated with a 2- to 3-fold decrease in 
binding affinity of f-Met-Leu-Phe to the formyl 
peptide receptor on these cells. Alterations in f- 
Met-Leu-Phe receptor interactions may explain the 
ability of PGEs and cAMP to inhibit membrane 
potential changes associated with cell stimulation. 
Additional studies to examine the specificity of 
PGE 1 and cAMP modulation of neutrophil ligand 
receptor interactions in vitro are currently in pro- 
gress. Although the use of cyanine dyes as indica- 
tors of changes in transmembrane potential is an 
indirect technique for studying electrical potential 
across cell membranes, several authors have dem- 
onstrated a high degree of correlation of stimulus- 
induced fluorescence changes with other indices of 
cell activation, suggesting that this technique is 
indeed a valid measure for examining membrane 
potential changes [1-3]. The relative contributions 
of plasmalemmal or intracellular organdie mem- 
brane potential changes to the changes in fluo- 
rescence intensity of cyanine dyes has been dis- 
cussed in the recent literature [3,37]. Although it is 
difficult to exclude the possibility that changes of 
mitochondrial membrane potentials contribute to 
the observed fluorescence changes associated with 
f-Met-Leu-Phe stimulation, it would appear that 
under our experimental conditions the observed 
changes in fluorescence of di(S)-C3-(5)-labeled cells 
most likely represent changes in plasmalemmal 
membrane potentials. 
In summary, our data indicate that 15-methyl- 
PGE1 and PGI 2 inhibit in a dose-dependent 
manner f-Met-Leu-Phe-induced transmembrane 
potential changes and functional responses of rat 
neutrophils. The lack of inhibiting effects of these 
agents on phorbol-myristate-acetate-induced mem- 
brane potential changes and superoxide-anion pro- 
duction suggest that this stimulus does not require 
the prostaglandin-sensitive step(s) to induce these 
cellular responses. The results confirm previous 
observations suggesting a close association, if not 
tight coupling, between transmembrane potential 
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